Metypred

Methylprednisolone, the active ingredient in Metypred, is a glucocorticoid presented as an oral tablet for oral use. It treats inflammatory and autoimmune conditions in adults and children as prescribed.

GNH USA supplies Metypred as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metypred, a glucocorticoid, is used to manage various inflammatory and immune‑mediated diseases.

- Allergic disorders: reduces inflammation and symptom severity. - Asthma and COPD exacerbations: improves airway function and shortens recovery time. - Rheumatoid arthritis and other inflammatory arthritides: decreases joint swelling and pain. - Dermatologic inflammatory conditions: alleviates skin redness and itching. - Autoimmune diseases: suppresses abnormal immune activity.

Adverse reactions may occur with systemic glucocorticoid therapy.

Common Side Effects: - Increased appetite and weight gain. - Insomnia or mood changes. - Elevated blood glucose levels. - Gastro‑intestinal discomfort or dyspepsia. - Fluid retention and mild hypertension. - Skin thinning or easy bruising.

Serious or Rare Side Effects: - Adrenal insufficiency on abrupt discontinuation. - Severe infections due to immunosuppression. - Osteoporosis and increased fracture risk. - Cataracts or glaucoma. - Psychosis or severe mood disorders. - Anaphylactic or severe allergic reactions.

Before initiating therapy, consider the following safety measures.

- Assess infection risk: screen for active or latent infections. - Monitor blood glucose: especially in diabetic patients. - Screen for osteoporosis: consider bone density testing for long‑term use. - Use the lowest effective dose: limit duration whenever possible. - Taper when discontinuing: avoid abrupt cessation to prevent adrenal crisis. - Store at ambient temperature: keep in the original pack, protect from moisture.

Methylprednisolone may interact with several drug classes.

Major Interactions (Avoid): - Potent CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin). - Live vaccines: risk of uncontrolled infection. - Anticoagulants such as warfarin: increased bleeding risk.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): additive gastrointestinal risk. - Diabetes medications: may require dose adjustment. - Inactivated vaccines: monitor immune response.